Reply

Affiliations

¹ Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
² Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany; F. Hoffmann-La Roche, Basel, Switzerland.
³ Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands.
⁴ Department of Ophthalmology, Centre Hospitalier Intercommunal de Creteil University Paris Est Creteil, Creteil, France.
⁵ Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
⁶ Department of Ophthalmology, Bergman Clinics B.V., Velp, the Netherlands.
⁷ Oxford Eye Hospital, John Radcliffe Hospital, Oxford, United Kingdom.
⁸ Department of Ophthalmology, Centre Hospitalier Intercommunal de Creteil University Paris Est Creteil, Creteil, France; Department of Ophthalmology, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Vita-Salute University, Milan, Italy.
⁹ Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands; Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: c.j.f.boon@lumc.nl.

Comment

Elon H C van Dijk et al. Ophthalmology. 2019 Apr.

. 2019 Apr;126(4):e30-e31.

doi: 10.1016/j.ophtha.2018.11.005.

¹ Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
² Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany; F. Hoffmann-La Roche, Basel, Switzerland.
³ Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands.
⁴ Department of Ophthalmology, Centre Hospitalier Intercommunal de Creteil University Paris Est Creteil, Creteil, France.
⁵ Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
⁶ Department of Ophthalmology, Bergman Clinics B.V., Velp, the Netherlands.
⁷ Oxford Eye Hospital, John Radcliffe Hospital, Oxford, United Kingdom.
⁸ Department of Ophthalmology, Centre Hospitalier Intercommunal de Creteil University Paris Est Creteil, Creteil, France; Department of Ophthalmology, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Vita-Salute University, Milan, Italy.
⁹ Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands; Department of Ophthalmology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: c.j.f.boon@lumc.nl.

No abstract available

Comment on

Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial.
van Dijk EHC, Fauser S, Breukink MB, Blanco-Garavito R, Groenewoud JMM, Keunen JEE, Peters PJH, Dijkman G, Souied EH, MacLaren RE, Querques G, Downes SM, Hoyng CB, Boon CJF. van Dijk EHC, et al. Ophthalmology. 2018 Oct;125(10):1547-1555. doi: 10.1016/j.ophtha.2018.04.021. Epub 2018 Jun 14. Ophthalmology. 2018. PMID: 29776672 Clinical Trial.
Re: van Dijk et al.: Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial (Ophthalmology. 2018;125:1547-1555).
Battaglia Parodi M, Iacono P. Battaglia Parodi M, et al. Ophthalmology. 2019 Apr;126(4):e29-e30. doi: 10.1016/j.ophtha.2018.11.004. Ophthalmology. 2019. PMID: 30910047 No abstract available.